“Benefits of semaglutide on chronic kidney disease outcomes by cardiovascular status or risk in the FLOW trial."
Publication Title
AHA Interview with Dr. C Michael Gibson
Document Type
Abstract
Publication Date
11-1-2024
Keywords
spokane; pmrc; washington
Area of Special Interest
Kidney & Diabetes
Specialty/Research Institute
Endocrinology
Specialty/Research Institute
Nephrology
